A survey of 300 OBGYN trials found zero provided protocols or materials statements, 10.58% addressed data availability, 5.82% mentioned preregistration, and over half omitted funding sources.
Tamiflu: the battle for secret drug data
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
q-bio.QM 1years
2019 1verdicts
ACCEPT 1representative citing papers
citing papers explorer
-
Evaluating the Reproducibility of Research in Obstetrics and Gynecology
A survey of 300 OBGYN trials found zero provided protocols or materials statements, 10.58% addressed data availability, 5.82% mentioned preregistration, and over half omitted funding sources.